# Peripheral Arterial Disease trials: 146 new since Nov 2024

Updated November 5, 2026.

146 clinical studies in Peripheral Arterial Disease were first posted on ClinicalTrials.gov from November 13, 2024 to November 5, 2026; 41 have an industry sponsor and 103 are recruiting or about to. The newest, NCT07919483, was posted on November 5, 2026: Daily Stretching to Improve Walking in Older Patients With Peripheral Artery Disease: The STRETCH PAD Study (Penn State University).

## The full list

New Peripheral Arterial Disease clinical trials: 146 rows for $7.30, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 7 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/condition/peripheral-arterial-disease

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 146
- Industry sponsored: 41
- Recruiting or not yet: 103
- Latest posted: November 5, 2026

## Newest trials

The newest 100 of 146, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 5, 2026 | NCT07919483 | Daily Stretching to Improve Walking in Older Patients With Peripheral Artery Disease: The STRETCH PAD Study | Penn State University | Not applicable | Not yet recruiting | Peripheral Artery Disease (PAD), Intermittent Claudication | 300 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919483) |
| October 28, 2026 | NCT07901478 | Plantar Load Analysis of Neuropathic and Neuroischaemic Diabetes-Related Foot Ulceration | The Leeds Teaching Hospitals NHS Trust | Observational | Completed | Foot Ulcers, Diabetic, Plantar Foot Pressure, Fat Pad Atrophy, Peripheral Arterial Disease | 16 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901478) |
| October 28, 2026 | NCT07901088 | A Bioequivalence and Safety Study of AJU-B718 and B718R in Healthy Adult Volunteers Under Fasting Conditions | AJU Pharm Co., Ltd. | Phase 1 | Not yet recruiting | Peripheral Arterial Disease | 40 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901088) |
| October 27, 2026 | NCT07897396 | The Effect of a Multimodal Preventive Intervention in Patients With Asymptomatic Peripheral Artery Disease | Värmland County Council, Sweden | Not applicable | Completed | Peripheral Arterial Disease, Asymptomatic Diseases, Ankle Brachial Index (0.9 or Less) | 16 | Sweden | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897396) |
| October 23, 2026 | NCT07891988 | Preventing Kidney Injury Using Carbon Dioxide as Contrast Medium in Patients With Peripheral Arterial Disease (PAD) and Chronic Kidney... | University of Leicester | Not applicable | Active not recruiting | Peripheral Arterial Disease, Chronic Kidney Diseases, Acute Kidney Injury | 184 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891988) |
| October 19, 2026 | NCT07881588 | Construction and Empirical Research of a Risk Prediction Model for Preventing Lower Extremity Arteriosclerosis Obliterans in Diabetic... | Second Affiliated Hospital of Nanchang University | Not applicable | Recruiting | Diabetes Mellitus, Peripheral Arterial Disease | 154 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881588) |
| October 16, 2026 | NCT07877129 | Exploring the Exercise Fear Experiences of Patients With Peripheral Arterial Disease: A Qualitative Study | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Observational | Completed | Peripheral Arterial Disease | 18 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07877129) |
| October 8, 2026 | NCT07864805 | Electromagnetic Therapy, Peripheral Vascular Diseases, Diabetes | Ashraf Abdelaal | Not applicable | Completed | Peripheral Arterial Disease (PAD), Diabete Type 2, Gait Abnormality, Quality of Life | 60 | Saudi Arabia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07864805) |
| October 6, 2026 | NCT07860138 | Hemodynamic Characteristics of Peripheral Arterial Disease Using Computational Fluid Dynamics | Fudan University | Observational | Not yet recruiting | Peripheral Arterial Disease | 14 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07860138) |
| October 1, 2026 | NCT07851766 | Neuromuscular Electrical Stimulation in Peripheral Arterial Disease | Halic University | Not applicable | Completed | Peripheral Arterial Disease(PAD), Peripheral Arterial Disease, Peripheral Arterial Diseases, Intermittent Claudicants | 48 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851766) |
| September 30, 2026 | NCT07850349 | Automated ABPI in Peripheral Arterial Disease a Pilot Study | Hull University Teaching Hospitals NHS Trust | Observational | Recruiting | Peripheral Arterial Disease (PAD), Ankle Brachial Index, Diagnostic Accuracy, Feasibility Studies | 400 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850349) |
| September 29, 2026 | NCT07848113 | Effect of Preoperative Ultrasound-Guided Stellate Ganglion Block on Postoperative Delirium in Older Adults Undergoing Elective Peripheral... | Assiut University | Not applicable | Not yet recruiting | Postoperative Delirium (POD), Peripheral Arterial Disease | 168 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07848113) |
| September 17, 2026 | NCT07825168 | Telerehabilitation in Patients With Peripheral Arterial Disease | Grigore T. Popa University of Medicine and Pharmacy | Not applicable | Completed | Peripheral Arterial Disease | 42 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07825168) |
| September 14, 2026 | NCT07816757 | Clinical Value of CT Perfusion in Peripheral Artery Disease | Fudan University | Observational | Not yet recruiting | Peripheral Artery Disease (PAD), CT Perfusion, Revascularization, Microcirculation, Prognosis | 200 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816757) |
| September 10, 2026 | NCT07814118 | Multimodal Physiologic State Intelligence Study | Truway Health, Inc. | Observational | Enrolling by invitation | Heart Failure, Cardiomyopathies, Pulmonary Hypertension, Myocarditis; Acute or Subacute, Myocarditis Due to Drug... | 25,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07814118) |
| September 4, 2026 | NCT07803718 | Rotational Atherectomy and Drug-Coated Balloon Angioplasty With Embolic Protection for Superficial Femoral Artery Occlusions | Sakarya University | Not applicable | Not yet recruiting | Peripheral Artery Disease, Atherectomy in Diseased Lower Extremity Arteries | 60 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07803718) |
| September 1, 2026 | NCT07796217 | Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy | Seoul National University Bundang Hospital | Phase 4 | Recruiting | Cardiac Event, Coronary Artery Disease, Peripheral Artery Disease, Bleeding | 2,758 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07796217) |
| August 26, 2026 | NCT07786623 | Spectroscopic Assessment of Tissue Oxygenation Changes During Vascular Surgery | Spectrocor | Observational | Not yet recruiting | Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia, Ischemia Vascular, Tissue Ischemia | 30 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07786623) |
| August 24, 2026 | NCT07782671 | The NICE-PAD II Trial | Northwestern University | Phase 3 | Not yet recruiting | Peripheral Artery Disease (PAD) | 250 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07782671) |
| August 13, 2026 | NCT07764016 | DCB Outcomes After Non-Compliant Balloon Vessel Preparation With or Without Scoring in Patients With Femoropopliteal Arterial Disease | Marc Sirvent | Not applicable | Not yet recruiting | Femoropopliteal Disease, Drug Coated Balloon, Critical Limb-Threatening Ischaemia, Peripheral Arterial Disease | 142 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07764016) |
| August 5, 2026 | NCT07747883 | IV-X Medical First-in-Human Peripheral Intravascular Lithotripsy Study for PAD | IVX Medical | Not applicable | Active not recruiting | Peripheral Artery Disease | 25 | Paraguay | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07747883) |
| August 5, 2026 | NCT07746362 | IV-X Medical Peripheral Intravascular Lithotripsy Study for PAD | IVX Medical | Not applicable | Not yet recruiting | Peripheral Artery Disease (PAD) | 140 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07746362) |
| August 3, 2026 | NCT07743021 | Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data | Center for Molecular Fingerprinting Research Nonprofit LLC | Observational | Recruiting | Non-communicable Diseases (NCD), Neoplams, Cancer, Lung Cancer (NSCLC), Cardiovascular Diseases (CVD), Atherosclerotic... | 15,000 | Hungary | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07743021) |
| July 29, 2026 | NCT07733076 | LineMatrix® Biological Vascular Graft for Infra-renal Arterial Bypass or Replacement | Shanghai Zhongshan Hospital | Not applicable | Not yet recruiting | Peripheral Arterial Disease | 15 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07733076) |
| July 28, 2026 | NCT07731997 | IVUS Guidance in BTK Interventions | Shin Kong Wu Ho-Su Memorial Hospital | Not applicable | Not yet recruiting | Chronic Limb-Threatening Ischemia | 212 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07731997) |
| July 23, 2026 | NCT07721584 | HeartMate App-Based Remote Monitoring for Cardiovascular Risk Factor Management | Yonsei University | Not applicable | Not yet recruiting | Cardiovascular Diseases, Heart Failure, Systolic, Coronary Artery Disease, Heart Valve Diseases, Peripheral Arterial... | 200 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07721584) |
| July 21, 2026 | NCT07716020 | XPAD European Feasibility Study | Xeltis | Not applicable | Not yet recruiting | Peripheral Arterial Disease | 15 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07716020) |
| July 15, 2026 | NCT07704190 | Effect of Secukinumab on Cardiorenal Outcomes in Patients With Cardiorenal Metabolic Syndrome and Atherosclerotic Cardiovascular Disease | Peking University Third Hospital | Phase 4 | Not yet recruiting | Cardiorenal Metabolic Syndrome, Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease, Coronary Artery... | 100 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07704190) |
| June 26, 2026 | NCT07672249 | Predictors of Major Adverse Limb Events After Endovascular Iliac Stenting: a Real-world Cohort Study | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | Observational | Recruiting | Peripheral Arterial Disease, Aortoiliac Occlusive Disease, Chronic Limb-Threatening Ischemia, Intermittent Claudication | 98 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07672249) |
| June 24, 2026 | NCT07665775 | Effectiveness of an Inpatient Rehabilitation and Prosthetic Training Model in Patients With Vascular and Metabolic Transfemoral Amputation | Instituto Nacional de Rehabilitacion | Observational | Not yet recruiting | Diabetes Mellitus, Transfemoral Amputation, Peripheral Arterial Disease, Vascular Thrombosis | 54 | Mexico | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07665775) |
| June 22, 2026 | NCT07658807 | Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease | Xuanwu Hospital, Beijing | Phase 3 | Not yet recruiting | Peripheral Arterial Disease, Diabetic Angiopathies, Arterial Occlusive Diseases | 300 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07658807) |
| June 17, 2026 | NCT07655206 | Home-based Exercise Therapy in Patients With Moderate to Severe Peripheral Artery Disease | Laval University | Not applicable | Recruiting | Peripheral Artery Disease | 12 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07655206) |
| June 17, 2026 | NCT07654231 | REducing Systemic Inflammation With LOw-dose Colchicine to ImproVE Cardiovascular Calcification in Chronic Kidney Disease: A Pilot... | University of Texas Southwestern Medical Center | Phase 2 | Not yet recruiting | Chronic Kidney Disease Mineral and Bone Disorder, Cognitive Function, Vascular Calcification, Coronary Artery... | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07654231) |
| June 10, 2026 | NCT07639853 | Case-Specific Health Care Professional Clinical Survey for Concerto Versa™ Detachable Coils | Medtronic Endovascular | Observational | Enrolling by invitation | Arteriovenous Malformation, Gastrointestinal Bleed, Gastric Varices, Hemorrhoid, Pelvic Venous Disorders, Peripheral... | 30 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07639853) |
| June 9, 2026 | NCT07637396 | Ankle-Brachial Index Changes Post Exercise and Its Effects on Patient-Centered Outcomes and Gait | Louisiana State University Health Sciences Center Shreveport | Observational | Not yet recruiting | Peripheral Arterial Disease(PAD) | 85 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07637396) |
| June 3, 2026 | NCT07622485 | In-Hospital Wearable-Based Monitoring Versus Standard Care in Cardiovascular Disease (INSPIRE) | Yonsei University | Not applicable | Not yet recruiting | Cardiovascular Diseases, Acute Coronary Syndrome, Heart Failure, Cardiac Arrhythmia, Peripheral Arterial Disease | 1,500 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07622485) |
| June 2, 2026 | NCT07619885 | The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate）and Plavix® in Healthy Participants | Shanghai CureGene Pharmaceutical Co., Ltd. | Phase 1 | Recruiting | Acute Coronary Syndromes (ACS), Recent Myocardial Infarction, Recent Stroke, Peripheral Arterial Disease | 136 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07619885) |
| May 29, 2026 | NCT07614386 | Radial Access Data in Vascular Interventions Registry | Mersin Medicalpark Hastanesi | Observational | Recruiting | Radial Artery Occlusion, Radial Artery Spasm, Vascular Access Complications, Coronary Artery Disease, Peripheral... | 20,000 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07614386) |
| May 29, 2026 | NCT07613840 | Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease | Massachusetts General Hospital | Not applicable | Recruiting | Peripheral Arterial Disease (PAD), Amputation, Thrombosis, Thrombosis (Stent Thrombosis), Platelet Aggregation... | 484 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07613840) |
| May 22, 2026 | NCT07602634 | Radiomics Features Predicting Outcomes of PAD | Zhijun Bao | Observational | Active not recruiting | Peripheral Artery Disease (PAD) | 200 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07602634) |
| May 20, 2026 | NCT07600385 | A Study to Evaluate the Efficacy and Safety of UI022/UI023 | Korea United Pharm. Inc. | Phase 3 | Completed | Peripheral Arterial Disease | 260 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07600385) |
| May 20, 2026 | NCT07599540 | Cardiovascular Risk in Peripheral Artery Disease Patients Undergoing Endovascular Revascularisation | University Medical Centre Ljubljana | Observational | Active not recruiting | Peripheral Arterial Disease, Myocardial Injury, Troponin, NT-proBNP, Echocardiography, Endovascular Procedures... | 500 | Slovenia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07599540) |
| May 19, 2026 | NCT07597239 | Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization | Massachusetts General Hospital | Not applicable | Active not recruiting | Thrombosis, Arterial Occlusive Diseases, Thromboelastography (TEG), Peripheral Arterial Disease(PAD), Stent Thrombosis... | 144 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07597239) |
| May 13, 2026 | NCT07582588 | Recreational Team Handball Programme for Patients With Peripheral Arterial Disease | University Institute of Maia | Not applicable | Not yet recruiting | Peripheral Arterial Disease (PAD) | 60 | Portugal | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07582588) |
| May 8, 2026 | NCT07575568 | Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal Lumen | Cagent Vascular LLC | Not applicable | Not yet recruiting | Peripheral Artery Disease | 30 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07575568) |
| April 24, 2026 | NCT07550959 | Evaluation of the Effectiveness of Hybrid Cardiac Rehabilitation in Peripheral Artery Disease | Biruni University | Not applicable | Not yet recruiting | Peripheral Arterial Disease | 40 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07550959) |
| April 17, 2026 | NCT07536373 | Colchicine in Chronic Limb-Threatening Ischemia | Shin Kong Wu Ho-Su Memorial Hospital | Phase 3 | Recruiting | Chronic Limb-Threatening Ischemia | 200 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07536373) |
| March 30, 2026 | NCT07499206 | Lymphatic Injury Visualization in Vascular Surgery | University Hospital, Basel, Switzerland | Not applicable | Not yet recruiting | Vascular Surgical Procedure, Peripheral Arterial Disease(PAD), Acute Ischemia, Hemmorhage, Aneurysm, Pseudoaneurysm | 60 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07499206) |
| March 27, 2026 | NCT07497360 | Tele-assessment and Face-to-face Assessment of the 30-second Sit-stand Test in Peripheral Artery Disease | Izmir Democracy University | Observational | Recruiting | Peripheral Arterial Disease | 45 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07497360) |
| March 16, 2026 | NCT07472439 | Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone in Europe | Angiodynamics, Inc. | Not applicable | Not yet recruiting | Peripheral Arterial Disease | 50 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07472439) |
| March 16, 2026 | NCT07472049 | Symptomatic and Systemic Atherosclerotic Plaque Activity in Patients With Peripheral Arterial Disease Using Novel Imaging | University of Edinburgh | Observational | Recruiting | Peripheral Arterial Disease, Chronic Limb Threatening Ischemia | 100 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07472049) |
| March 13, 2026 | NCT07471087 | Chocolate Balloon vs Standard Balloon Angioplasty Before Drug-Coated Balloon Treatment for Femoropopliteal Artery Narrowing or Blockage | Felice Pecoraro | Not applicable | Not yet recruiting | Peripheral Artery Disease (PAD), Femoropopliteal Artery Disease, Vascular Lesion Preparation, Critical Limb-Threatening... | 242 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07471087) |
| March 12, 2026 | NCT07465627 | Vessel Recoil in Specific CLTI Populations | Medical University of Graz | Observational | Recruiting | Chronic Limb Threatening Ischemia | 40 | Austria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07465627) |
| March 11, 2026 | NCT07464990 | Deep Breathing Exercise for Pain and Hemodynamic Stability in Patients After Peripheral Percutaneous Angioplasty | Kufa University | Not applicable | Completed | Peripheral Arterial Disease | 100 | Iraq | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07464990) |
| March 4, 2026 | NCT07449546 | Periodontal Status and TMAO Levels in Peripheral Artery Disease | Ankara University | Observational | Completed | Periodontal Diseases, Edentulism, Peripheral Arterial Disease | 61 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07449546) |
| February 25, 2026 | NCT07433309 | CT Body Composition as Predictor of Exercise Therapy Outcome in Peripheral Arterial Disease | Nemocnice AGEL Trinec-Podlesi a.s. | Observational | Not yet recruiting | Sarcopenia, Body Composition, Sarcopenic Obesity, Peripheral Arterial Disease | 128 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07433309) |
| February 23, 2026 | NCT07427108 | Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety | Sohag University | Not applicable | Recruiting | Peripheral Arterial Disease, Vascular Diseases | 32 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07427108) |
| February 9, 2026 | NCT07397494 | Near Infrared Spectroscopy Imaging of Change in Tissue Oxygenation to Assess Peripheral Artery Disease | Kent Imaging Inc | Observational | Not yet recruiting | Peripheral Arterial Disease | 200 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07397494) |
| February 9, 2026 | NCT07397390 | an Observational Study Evaluting the Effectiveness and Safety of DKutting LL Noval Scoring Balloon Angioplasty for Vessel Preparation... | The First Affiliated Hospital of Dalian Medical University | Observational | Enrolling by invitation | Femoral Artery Stenosis, Angioplasty, Cutting Balloon Angioplasty, Calcifications, Vascular, Intravascular Imaging... | 58 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07397390) |
| February 4, 2026 | NCT07385573 | A Single Arm Trial to Evaluate the Safety and Efficacy of the Long (\> 150mm) PasseoTM-18 LuxTM Drug-coated Balloon in the Treatment of... | KANDO Research | Not applicable | Recruiting | Drug Coated Balloon, Peripheral Arterial Disease | 200 | Belgium | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07385573) |
| January 29, 2026 | NCT07374601 | The Value of Super-resolution Ultrasound Imaging for Peripheral Artery Disease | Peking University First Hospital | Observational | Recruiting | Peripheral Artery Disease | 300 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07374601) |
| January 22, 2026 | NCT07359807 | A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in... | Concept Medical Inc. | Phase 2/3 | Not yet recruiting | Popliteal Artery Disease, Superficial Femoral Artery Disease | 478 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07359807) |
| January 21, 2026 | NCT07353905 | Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries | Baylor Research Institute | Not applicable | Recruiting | Peripheral Arterial Disease, Lower Extremity Arterial Disease | 350 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07353905) |
| January 14, 2026 | NCT07340112 | Expression of GLP1 Receptor on Peripheral Blood Mononuclear Cells in Advanced Peripheral Artery Disease: Paving the Way for GLP1R Agonists... | University Hospital, Strasbourg, France | Observational | Not yet recruiting | Peripheral Arterial Disease (PAD), Claudication, Intermittent, Chronic Limb-Threatening Ischemia | 50 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07340112) |
| January 13, 2026 | NCT07336381 | Shortwave Diathermy In-home Treatment for Indianapolis VA-only Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy | Indiana University | Not applicable | Withdrawn | Peripheral Arterial Disease, Peripheral Neuropathy | 0 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07336381) |
| January 13, 2026 | NCT07335341 | Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System | Medtronic Endovascular | Observational | Completed | Venous Embolism of Lower Extremities (Diagnosis), Arterial Embolism and Thrombosis, Acute DVT of Lower Extremity... | 51 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07335341) |
| January 12, 2026 | NCT07334834 | Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic... | Colorado Prevention Center | Not applicable | Recruiting | Hyperlipidemia | 100 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07334834) |
| January 9, 2026 | NCT07328646 | BEHAVIOR CHANGE INTERVENTION AFTER ENDOVASCULAR REVASCULARIZATION IN PAD | Muğla Sıtkı Koçman University | Not applicable | Completed | BEHAVIOR CHANGE-BASED PHYSICAL ACTIVITY INTERVENTION IN PAD PATIENTS AFTER ENDOVASCULAR REVASCULARIZATION | 32 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07328646) |
| January 7, 2026 | NCT07322913 | Intervascular Post-Market Clinical Follow-Up (PMCF) Registry | Intervascular | Observational | Recruiting | Carotid Artery Diseases, Aortic Diseases, Peripheral Arterial Diseases | 1,200 | Belgium, France, Spain, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07322913) |
| January 6, 2026 | NCT07318610 | Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease | Regeneron Pharmaceuticals | Phase 3 | Recruiting | Peripheral Artery Disease (PAD) | 7,050 | United Kingdom, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07318610) |
| January 5, 2026 | NCT07318155 | A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease | Sirius Therapeutics Co., Ltd. | Phase 2 | Recruiting | Coronary Artery Disease (CAD), Peripheral Arterial Disease | 104 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07318155) |
| January 2, 2026 | NCT07313410 | Using Near-Infrared Light to Better Understand Peripheral Artery Disease | The University of Texas at Arlington | Observational | Recruiting | Peripheral Artery Disease (PAD) | 120 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07313410) |
| December 18, 2025 | NCT07290673 | Evaluating the Efficacy of FoundationDRS Solo in Addition to Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers | Samaritan Biologics | Not applicable | Not yet recruiting | Diabetic Foot Ulcer (DFU) | 124 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07290673) |
| December 15, 2025 | NCT07283289 | Prevalence of Obstructive Sleep Apnea in Patients With Peripheral Arterial Occlusive Disease | Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer | Observational | Recruiting | Peripheral Artery Disease | 295 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07283289) |
| December 12, 2025 | NCT07279649 | GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Post-Market Clinical Follow-Up (PMCF) Observational Registry (RE-PROVE) | W.L.Gore & Associates | Observational | Recruiting | Aorto-iliac Occlusive Disease (AIOD), Visceral Artery Occlusive Disease (VAOD), Isolated Artery Aneurysms (IAA), Trauma... | 240 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07279649) |
| December 11, 2025 | NCT07277218 | Drug-coated Balloons Versus Drug-eluting Stents for the Treatment of Femoropopliteal In-Stent Restenosis | Chunshui He | Observational | Not yet recruiting | Femoropopliteal In-Stent Restenosis (ISR) | 600 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07277218) |
| December 8, 2025 | NCT07270575 | REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapopliteal Artery Disease in Patients With Chronic Limb-threatening... | Cardiovascular and Interventional Radiological Society of Europe | Observational | Recruiting | Chronic Limb Threatening Ischemia, Chronic Limb-Threatening Ischemia | 400 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07270575) |
| December 8, 2025 | NCT07270562 | ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia | Cardiovascular and Interventional Radiological Society of Europe | Observational | Recruiting | Chronic Limb Threatening Ischemia, Chronic Limb-Threatening Ischemia | 250 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07270562) |
| December 3, 2025 | NCT07262203 | Effect of Diabetic Foot Exercises on Peripheral Vascular Status in Type 2 Diabetes Mellitus Patients | Universitas Muhammadiyah Surakarta | Not applicable | Completed | Peripheral Artery Disease (PAD), Diabetes Mellitus Type 2, Diabetic Foot Circulation Impairment | 44 | Indonesia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07262203) |
| November 26, 2025 | NCT07250776 | Effects of Body Awareness Therapy on Functional Capacity, With Peripheral Artery Disease | Karadeniz Technical University | Not applicable | Completed | Peripheral Arterial Disease | 51 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07250776) |
| November 10, 2025 | NCT07226193 | Detecting Peripheral Artery Disease With the Pulse | University of Nebraska | Not applicable | Recruiting | Peripheral Artery Disease (PAD) | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07226193) |
| November 3, 2025 | NCT07223593 | Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease | Eli Lilly and Company | Phase 3 | Recruiting | Peripheral Arterial Disease | 1,205 | Argentina, Australia, Brazil, Canada, China, France, Greece, India, Israel... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07223593) |
| October 31, 2025 | NCT07223437 | REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center | University of Tennessee Graduate School of Medicine | Not applicable | Recruiting | Peripheral Arterial Disease | 81 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07223437) |
| October 7, 2025 | NCT07209527 | Truway Diagnostic Tools in Primary Care | Truway Health, Inc. | Early phase 1 | Enrolling by invitation | Chronic Disease, Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight, Hypertension, Cardiovascular Disease Acute... | 200 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07209527) |
| October 6, 2025 | NCT07209085 | A Study to Evaluate the Safety and Effectiveness of the FastWave Artero™ Peripheral Intravascular Lithotripsy (IVL) System in Adults With... | FastWave Medical | Not applicable | Not yet recruiting | Peripheral Artery Disease (PAD) | 110 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07209085) |
| October 1, 2025 | NCT07201168 | Structured Educational Program vs Standard Care in Pre-surgical Critical Limb Ischemia Patients | Tulip Medicine | Not applicable | Completed | Chronic Limb-Threatening Ischemia, Peripheral Arterial Disease, Health Education | 184 | Kazakhstan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07201168) |
| September 23, 2025 | NCT07187700 | Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression: the Prospective... | Amsterdam UMC | Observational | Not yet recruiting | Abdominal Aorta Aneurism, Peripheral Arterial Disease | 1,100 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07187700) |
| September 18, 2025 | NCT07181434 | Impact of Virtual Reality on Patient Pain During Lower Limb Revascularization Via Endovascular Surgery Under Local Anesthesia With Sedation | Poitiers University Hospital | Not applicable | Recruiting | Peripheral Arterial Disease | 90 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07181434) |
| September 16, 2025 | NCT07175129 | Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI) | University Hospitals Cleveland Medical Center | Not applicable | Withdrawn | Chronic Limb Threatening Ischemia | 0 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07175129) |
| September 15, 2025 | NCT07173062 | Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome | Universidade do Porto | Not applicable | Recruiting | Stroke, Coronary Arterial Disease (CAD), Myocardial Infarction (MI), Diabetes Mellitus, Peripheral Artery Disease... | 150 | Portugal | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07173062) |
| September 11, 2025 | NCT07169513 | Mechanistic Study of Anti-Platelet Therapy in Atherosclerosis | Guy's and St Thomas' NHS Foundation Trust | Not applicable | Not yet recruiting | Peripheral Arterial Disease, Silent Atherosclerosis | 60 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07169513) |
| September 11, 2025 | NCT07169045 | Validity and Reliability of the 6-minute Stepper Test in Patients With Peripheral Artery Disease | Gazi University | Observational | Recruiting | Peripheral Artery Disease (PAD) | 24 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07169045) |
| September 8, 2025 | NCT07161583 | Advanta VXT and Flixene PMCF Registry | Atrium Medical Corporation | Observational | Recruiting | Peripheral Arterial Disease | 1,000 | France, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07161583) |
| September 5, 2025 | NCT07157475 | Vascular Complications in Patients Undergoing Peripheral Revascularization and Taking SGLT-2 Inhibitors | Wroclaw Medical University | Observational | Recruiting | Peripheral Arterial Disease(PAD) | 300 | Poland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07157475) |
| August 27, 2025 | NCT07144150 | EVERO Drug-coated Balloon (DCB) Randomized Trial | Cook Research Incorporated | Not applicable | Recruiting | Peripheral Vascular Disease, Peripheral Arterial Disease | 410 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07144150) |
| August 27, 2025 | NCT07142655 | An Observational Study to Learn More About the Safety of Rivaroxaban in Participants With Peripheral Arterial Disease Who Had Surgery to... | Bayer | Observational | Completed | Peripheral Arterial Disease (PAD) | 1,500 | Japan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07142655) |
| August 22, 2025 | NCT07136883 | DCB Outcomes After Plain or Scoring Balloon for Vessel Preparation in Patients With Femoropopliteal Arterial Disease | Marc Sirvent | Not applicable | Completed | Femoropopliteal Disease, Drug Coated Balloon, Critical Limb Ischemia (CLI), Peripheral Arterial Disease | 83 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07136883) |
| August 19, 2025 | NCT07130526 | Distrupt Stiffness Trial | University Hospital, Essen | Not applicable | Recruiting | PAD - Peripheral Arterial Disease, PAD | 40 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07130526) |
| August 14, 2025 | NCT07122167 | Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery... | MDCECRO LLC | Not applicable | Recruiting | Peripheral Arterial Disease | 153 | Poland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07122167) |
| August 8, 2025 | NCT07112547 | Occurrence of Severe Cardiac Rhythm and Conduction Disturbances in Emergency Department Patients With Non-ST Elevation Acute Coronary... | University Hospital, Strasbourg, France | Observational | Not yet recruiting | Acute Coronary Syndrome Without ST Elevation on Electrocardiogram, Acute Coronary Syndromes (ACS), Myocardial... | 500 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07112547) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Fudan University | 3 | October 6, 2026 |
| Massachusetts General Hospital | 3 | May 29, 2026 |
| Truway Health, Inc. | 2 | September 10, 2026 |
| Northwestern University | 2 | August 24, 2026 |
| Marc Sirvent | 2 | August 13, 2026 |
| IVX Medical | 2 | August 5, 2026 |
| Shin Kong Wu Ho-Su Memorial Hospital | 2 | July 28, 2026 |
| Yonsei University | 2 | July 23, 2026 |
| Laval University | 2 | June 17, 2026 |
| Medtronic Endovascular | 2 | June 10, 2026 |
| Cagent Vascular LLC | 2 | May 8, 2026 |
| Angiodynamics, Inc. | 2 | March 16, 2026 |
| University Hospital, Strasbourg, France | 2 | January 14, 2026 |
| Cardiovascular and Interventional Radiological Society of Europe | 2 | December 8, 2025 |
| Tulip Medicine | 2 | October 1, 2025 |
| University Hospital, Essen | 2 | August 19, 2025 |
| HJN Sverige AB/Neko Health | 2 | May 25, 2025 |
| Penn State University | 1 | November 5, 2026 |
| The Leeds Teaching Hospitals NHS Trust | 1 | October 28, 2026 |
| AJU Pharm Co., Ltd. | 1 | October 28, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 66 | November 5, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 58 | October 28, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 8 | August 24, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 5 | September 1, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 4 | June 17, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 2 | October 28, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 2 | October 7, 2025 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 1 | January 22, 2026 |

## By country

| Country | New trials | Latest |
| --- | --- | --- |
| [United States](https://specstream.ai/data/clinical-trials/country/united-states) | 31 | November 5, 2026 |
| [China](https://specstream.ai/data/clinical-trials/country/china) | 14 | October 19, 2026 |
| [Turkey (Türkiye)](https://specstream.ai/data/clinical-trials/country/turkey-t-rkiye) | 11 | October 1, 2026 |
| [United Kingdom](https://specstream.ai/data/clinical-trials/country/united-kingdom) | 10 | October 28, 2026 |
| [France](https://specstream.ai/data/clinical-trials/country/france) | 8 | January 14, 2026 |
| [Spain](https://specstream.ai/data/clinical-trials/country/spain) | 7 | January 7, 2026 |
| [Germany](https://specstream.ai/data/clinical-trials/country/germany) | 6 | December 12, 2025 |
| [Poland](https://specstream.ai/data/clinical-trials/country/poland) | 6 | November 3, 2025 |
| [South Korea](https://specstream.ai/data/clinical-trials/country/south-korea) | 5 | October 28, 2026 |
| [Italy](https://specstream.ai/data/clinical-trials/country/italy) | 5 | June 26, 2026 |
| [Belgium](https://specstream.ai/data/clinical-trials/country/belgium) | 5 | February 4, 2026 |
| [Taiwan](https://specstream.ai/data/clinical-trials/country/taiwan) | 4 | July 28, 2026 |
| [Canada](https://specstream.ai/data/clinical-trials/country/canada) | 4 | June 17, 2026 |
| [Brazil](https://specstream.ai/data/clinical-trials/country/brazil) | 4 | November 3, 2025 |
| [Sweden](https://specstream.ai/data/clinical-trials/country/sweden) | 3 | October 27, 2026 |
| [Japan](https://specstream.ai/data/clinical-trials/country/japan) | 3 | November 3, 2025 |
| [Romania](https://specstream.ai/data/clinical-trials/country/romania) | 2 | September 17, 2026 |
| [Hungary](https://specstream.ai/data/clinical-trials/country/hungary) | 2 | August 3, 2026 |
| [Portugal](https://specstream.ai/data/clinical-trials/country/portugal) | 2 | May 13, 2026 |
| [Switzerland](https://specstream.ai/data/clinical-trials/country/switzerland) | 2 | March 30, 2026 |
| [Austria](https://specstream.ai/data/clinical-trials/country/austria) | 2 | March 12, 2026 |
| [Egypt](https://specstream.ai/data/clinical-trials/country/egypt) | 2 | February 23, 2026 |
| [Indonesia](https://specstream.ai/data/clinical-trials/country/indonesia) | 2 | December 3, 2025 |
| [Greece](https://specstream.ai/data/clinical-trials/country/greece) | 2 | November 3, 2025 |
| [Netherlands](https://specstream.ai/data/clinical-trials/country/netherlands) | 2 | November 3, 2025 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).